China's Biotech Plan

China's biotechnology industry is likely to reach a total output value of 4 trillion yuan — $630 billion — by the end of 2015, reports China Daily's Gao Yuan. The pharmaceutical sector is expected to contribute about 90 percent of that value, Yuan says, adding that, according to China Securities Journal, the country's government is considering a five-year development plan for the industry.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.